Stock Market Profiles

STLD (STEEL DYNAMICS INC) P/E: 17 GAAP DILUTED YEAR-OVER-YEAR EPS GROWTH: $.56 SECTOR: NON-ENERGY MINERALS ASSETS-LIABILITIES: 1.81 DIVIDEND: 1.7% STLD is a company endeavoring in the production of steel. They are listed on the Nasdaq, and beat Wall Street expectations by 11% when they last report. The company will announce Q2 2017 earnings after market close 7/19/17. On a year-over-year basis, STLD increased its sales by 35%. Cost of goods increased only 27%, and income tax expense nearly tripled. With the exception of nickel, all steel raw resources have increased in price over the past year. Profit sharing rose by a similar margin as income tax expense. Net income increased by 27%, and the amount of shares was decreased minimally. Steel Dynamics has less than half of the value of its long-term debt in cash. Inventories increased only 6%. The company has commodity futures contracts shorting aluminum and copper. STLD has risen 2.6% year...

TDOC (TELADOC, INC) P/E: n/a GAAP DILUTED YEAR-OVER-YEAR EPS GROWTH LAST QUARTER: $.1 SECTOR: HEALTH SERVICES ASSETS-LIABILITIES: 22 DIVIDEND: none TDOC is the ticker for Teladoc, a telemedicine company specializing in subscription services. The company provides companies access to consult with licensed physicians 24 hours a day with the subscription model. A recent IPO, TDOC is not yet profitable, and has consistent revenue growth. TDOC increased its revenue 60% on a year-over-year basis when it reported last 5/8/17. They increased advertising budget nearly 50% to support strong revenue growth, while their “legal” budget was diminished significantly. “Technology and development” increased about 25%, and sales costs increased 50%. While overall net loss actually increased on a year-over-year basis, EPS was reported as increased due to an increase in the amount of shares outstanding. The reported EPS beat wall street expectations, and revenue beat...

PGR (PROGRESSIVE CORP) P/E: 21.7 GAAP DILUTED YEAR-OVER-YEAR EPS GROWTH LAST QUARTER: $.25 SECTOR: FINANCE ASSETS-LIABILITIES: 1.35 DIVIDEND: 1.53% Progressive is an insurance company founded in 1937. Up 25% YTD, PGR will report earnings in mid July, looking to extend the streak. PGR dispenses its 1.53% dividend in one large yearly chunk. Progressive managed to increase underwriting margin by approximately 60% while increasing total revenue by 13% on a year-over-year basis. While the company claims to have more assets than liabilities, it has less than 8% of its debt in cash. However, because Progressive makes money by investing its revenue from premiums, it would lose profit capability by having the majority of its funds in cash. The revenue earned from premiums is nearly 60 times the company's investment income, which is concentrated in company debt securities and government obligations. While EPS has beat Wall Street expectations 6 out of...

ISRG (INTUITIVE SURGICAL INC) P/E: 48 GAAP DILUTED YEAR-OVER-YEAR EPS GROWTH LAST QUARTER: $1.13 SECTOR: HEALTH TECHNOLOGY ASSETS-LIABILITIES: 7.05 DIVIDEND: none ISRG is the ticker for Intuitive Surgical Inc, a company endeavoring in the manufacture and distribution of robotic surgical devices. The company recently gained FDA approval for a lower-cost device. They have a clean balance sheet with a history of upside surprises against earnings expectations, and report again 7/20/17. Revenues increased nearly 14%, while EPS increased 32% compared to the Q1 '16 results. While liabilities decreased on a year-over-year basis, assets decreased by a larger margin. R&D spending increased 36%, and administrative costs rose 16%. Taxes were cut in half, although the revenues increased, due to modified accounting principles, and tax benefits for the employee share-based compensation.. The ratio of assets-liabilities decreased from 9.14 to 7.05, which is...

EXEL (EXELISIS INC) P/E: 800 GAAP DILUTED YEAR-OVER-YEAR EPS GROWTH LAST QUARTER: $.31 SECTOR: HEALTH TECHNOLOGY ASSETS-LIABILITIES: 1.24 DIVIDEND: none Exilixis is a pharmaceutical company specializing in cancer drugs. The company is up already over 60% YTD. It is heavily owned by the major institutions. In each of the last 4 quarters, EXEL has beat Wall Street expectations, according to Estimize. The last two quarters have been profitable, and the company has set its expectations for profitable quarters in the future. Previously, the company posted consistent losses. Revenue increased approximately 550% on a year-over-year basis, while collaborative revenue doubled. EXEL has partnerships with Roche and GlaxoSmithKline. Cabometyx, a rectal cancer drug, is its largest revenue source in the latest quarter and most recent drug launch for the company. Exelixis announced that their R&D budget decreased due to decreased costs in one of their drug s...

JWA (JOHN WILEY AND SONS) P/E: 31.4 GAAP DILUTED YEAR-OVER-YEAR EPS GROWTH LAST QUARTER: $.15 SECTOR: Consumer Services ASSETS-LIABILITIES: 3.29 DIVIDEND: 2.28% John Wiley and Sons is a company that provides research resources, online project management, and publishing services. The company is best known for its 'For Dummies' series, and reported after the bell 6/13/17. JWA beat EPS estimates by $.11. A close analysis of the earnings report released 6/13/17 shows EPS increased at a significantly higher rate than revenue. JWA significantly cut administrative costs, and revenue did increase, leading to a sizable increase in EPS. The company has a large share buyback and dividend program. While it has over three times as much assets on the book as it does liabilities, the company does not include long-term debt in its accounting for liabilities. JWA has approximately 15% as much cash as it does long-term debt. The company cut its long-term deb...

ONE UP ON WALL STREET PETER LYNCH SUMMARY Lynch opens the book with the contention that the average investor can perform as well as most experts.  He dubs stocks that earn ten times of initial investment amount as "tenbaggers."  Money for investing can be saved through minor lifestyle adjustments.  Although the author attends many functions with high-level market professionals, he still finds many of his stock picks in his everyday life.  The novel is divided into three portions: preparing to invest, picking winners, and long-term view.  He states that there is no such thing as a born stockpicker, and that picking stocks is an art rather than a science, and as such cannot be quantified. The author worked as a caddy in his youth and traded golfing advice for stock picks.  He utilizes the term "street lag" to describe the amount of time between when consumers recognize a good product and when wall street recognizes the company.  Some stock...

AMGN P/E: 16.1 GAAP EPS Y-O-Y GROWTH LAST QUARTER: $.22 SECTOR: HEALTH TECHNOLOGY ASSETS-LIABILITIES: 1.62 DIVIDEND: 2.54% Amgen is a leading biotech company with a solid financial foundation. It has managed to reduce its spending on research and development while increasing revenue through its sales of established drugs such as Enbrel, and Prolia. The company has several rapidly growing drugs that are newer to the market, with many drugs in the company's pipeline. In its last quarter, Amgen posted 7.7% revenue growth with 7.5% net income growth. The company spent less, however, in the most recent quarter when compared with the comparable quarter from the prior year, on research and development. The reduction in operating margin came from an increased interest expense in the quarter. Although the company spent less on research and development, its revenue did increase. Amgen is continuing to innovate despite reduced research and development b...

MHK (MOHAWK INDUSTRIES) P/E: 18.6 GAAP DILUTED EPS Y-O-Y GROWTH LAST QUARTER: $.44 SECTOR: CONSUMER DURABLES ASSETS-LIABILITIES: 2.312 DIVIDEND: none Mohawk industries is a stock you probably have not heard of, unless you are a DIY enthusiast or work in homebuilding. Mohawk is a supplier of carpet, wall tiles, and laminate. They have posted consistent revenue increases over the last 5 years. In 2016, the company spent a record amount on capital investing in order to continue the growth of its business, and plans to expand on that strategy in 2017. The company is dedicating itself to expansion of manufacturing capacity and development of new products, rather than acquisitions. This capital expenditure has not slowed the company's growth, however, as its operating income margin has also increased over the last 5 years. Jeffrey Lorberbaum, the company's CEO, is the son of the owners of a flooring company which was acquired by Mohawk. Lorberbaum...

UNH (UNITED HEALTHCARE) P/E: 23.2 GAAP DILUTED EPS GROWTH Q4 '15 TO Q4 '16: $.71 SECTOR: HEALTH SERVICES ASSETS-LIABILITIES: 2.54 DIVIDEND: 1.52% In 2015, UNH was the largest provider of health insurance in the United States of America. Unless the United States develops a national health insurance plan like many other nations of the world, health insurance will continue to be a booming business. People can not do without health insurance, or they will be forced to pay astronomical out-of-pocket costs. United Healthcare has shown itself to be the strongest company in the sector. The healthcare industry is set to change under President Trump. Healthcare will no longer be mandatory. Medicaid expansion, although opposed by the new leadership, will remain in place until 2020 due to laws already passed by the previous administration. People without healthcare through employment will be offered tax credits based on income and other factors in order ...

BAC (BANK OF AMERICA) P/E: 15.3 GAAP DILUTED EPS Y-O-Y GROWTH LAST QUARTER: $.19 SECTOR: FINANCE ASSETS-LIABILITIES: 1.7 DIVIDEND: 1.19% The largest bank in the US based on deposits, Bank of America lost .29% of its market share in 2016. With the financial sector performing well recently, Bank of America has risen $12.7 per share since 6/2016 and $8.7 per share since 11/2016. With a relatively low P/E of 16.9, the stock may continue to rise, fueled by its recent growth in revenue and profits. Despite losing .29% of its market share in 2016, Bank of America posted a year-over-year income increase of 14.5% on a 2% revenue gain in the last quarter. Income derived from global market business increased 284%, driven by a strong step forward in revenue and supplemented by a substantial decrease in costs. Real estate, and banking profits increased, as well, and the company reduced its losses from other sectors. With a 1.19% dividend growth, an investor can expe...

LMT (LOCKHEED MARTIN) P/E: 21.7 GAAP DILUTED EPS Y-O-Y GROWTH LAST QUARTER: $.31 SECTOR: ELECTRONIC TECHNOLOGY ASSETS-LIABILITIES: 1.03 DIVIDEND: 1.82 LMT is a defense company branded as a technology stock. Although Aerospace and Defense is a field in which a large amount of money is invested for the wellbeing of the country, the largest brands are not always as visible to the common consumer as a storefront one sees on the street, or a company that advertises constantly on our computers, televisions, and radios. However, while our tax dollars are going to Aerospace and Defense, I see no reason why we, the common consumers, should not profit off of the best companies in the sector. As the largest company in the sector, LMT gives the best probability of profit. The bulk of Lockheed Martin's profit is derived from its aeronautics segment, according to its financial data available on the company's investor relations site. Lockheed Martin is substanti...

FL (FOOT LOCKER) P/E: 15.2 GAAP DILUTED YO-Y EPS GROWTH LAST QUARTER: $.28 SECTOR: RETAIL TRADE ASSETS-LIABILITIES: 3.39 DIVIDEND: 1.68% According to statisticbrain, Foot Locker was the largest shoe retailer in the United States as of 8/13/2016. Foot Locker posted a 24.5% year-over-year EPS gain in the most recent quarter, meaning its successful business is still growing. The company has a low price-to-earnings multiple and a high rate of growth with solid financials, giving the stock room to climb. While many retail stores have faired poorly due to the recent emergence of Amazon and other online retailers, Foot Locker does not suffer because their services are hard to duplicate online. You can not try on a shoe from Amazon prior to purchasing, for example. For customers who do not need to try on the shoe, either because they have already purchased the same shoe, or have tried on shoes of the same brand, Foot Locker also sells shoes through Amazon. In th...